In a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque growth, which cause heart disease. Their insight is the basis for a promising therapeutic approach to halt and potentially reverse plaque buildup and the progression of disease, the researchers said.
The study was published online by Nature Metabolism.
Current treatments for plaque and hardened arteries, a condition known as atherosclerosis, can slow but not improve the disease. Experts believe that may be due to ongoing inflammation in blood vessels. To understand the factors contributing to this inflammation, the research team focused on a group of proteins, called transforming growth factor beta (TGFß), that regulates a wide range of cells and tissues throughout the body.
Using cultured human cells, the researchers discovered that TGF? proteins trigger inflammation in endothelial cells — the cells that form the inner lining of artery walls — but not in other cell types. With a technique called single cell RNA-seq analysis, which measures the expression of every gene in single cells, they then showed that TGF? induced inflammation in these cells in mouse models. This finding was notable, said the researchers, because TGF? proteins are known to decrease inflammation in other cells in the body.
The researchers also showed that when the TGF? receptor gene is deleted in endothelial cells, both the inflammation and plaque in blood vessels are significantly reduced.
To test this approach as a potential therapy, the team, led by professor of medicine Michael Simons, M.D., used an “interfering” RNA, or RNAi, drug developed at Yale, to disrupt TGFß receptors. Interfering RNA use a gene’s own DNA sequence to turn off or silence the gene. To deliver the drug only to endothelial cells in the blood vessel walls of mice, they employed microscopic particles, or nanoparticles, created by their co-authors at MIT. This strategy reduced inflammation and plaque as effectively as the genetic technique.
The findings identify TGFß signaling as a major cause of chronic vessel wall inflammation, and demonstrate that disruption of this pathway leads to cessation of inflammation and substantial regression of existing plaque, said the scientists.
Based on this discovery, investigators at Yale and MIT have launched a biotech company, VasoRX, Inc., to develop this targeted approach, using the RNAi drug delivered by nanoparticles as a potential therapy for atherosclerosis in people.
Learn more: Yale-led study offers promising approach to reducing plaque in arteries
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Atherosclerosis
- Top 5 Health Benefits of Lemon: Immunity, Skin Health, and Moreon April 28, 2024 at 3:30 am
However you like to enjoy this flavorful fruit, you’re going to want to eat more of it after hearing what registered dietitians have to say about the potential health benefits of lemons. Lemons are ...
- Giloy Juice For Lowering High Cholesterol: Expert Lists How This Juice Helps In Managing Cholesterol Levelson April 28, 2024 at 1:10 am
Giloy juice offers a natural and effective way to lower Low-Density Lipoprotein LDL cholesterol levels and promote heart health ...
- Vaping, even once, may raise the risk of heart failure, study findson April 27, 2024 at 4:00 am
A new study indicates that people who have used a vape at any point in their lives are 19% more likely to experience heart failure compared to people who have never used them.
- Irregular bone marrow cells may increase heart disease riskon April 26, 2024 at 4:00 am
Over time, bone marrow stem cells develop key genetic errors and pass them on to immune cells. This may increase the risk of developing heart disease.
- Exercise can ease peripheral artery disease symptomson April 25, 2024 at 12:56 pm
Patricia Creque describes herself as "one of those people who has music in my head and am always ready to dance." ...
- What is high cholesterol and can statin drugs help? Here are 3 things to knowon April 25, 2024 at 2:01 am
There can be a genetic link for high cholesterol, but for the majority of us, lifestyle and diet will be the key deciding factors in how high it goes.
- Is It Safe To Consume Spinach Daily? A Review By Nutrition Professionalson April 23, 2024 at 2:28 pm
Expert opinion from Isis Lima Souza Bachelor in Nutrition · 11 years of experience · Brazil The health benefits of spinach include skin care, improved eyesight, regulated blood pressure, stronger ...
- Spanish scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndromeon April 22, 2024 at 12:21 pm
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare genetic disease that affects just 1 in every 20 million people; it is estimated that fewer than 400 children in the world have the ...
- Ancient Alleles Shed Light on Atherosclerosis Riskon April 19, 2024 at 7:20 am
Calculating the polygenic risk scores of ancient humans such as Ötzi the iceman helps researchers understand the genetic predisposition to cardiovascular disease.
- What Happens When You’ve Been on Ozempic for 20 Years?on April 15, 2024 at 12:47 pm
After all, the FDA has deemed these drugs safe for use, and doctors have been prescribing products in this class to diabetes patients for 20 years with little evidence of long-term harm. Make your ...
via Bing News